Discovery of the Receptor That MK-677 and GHRPs Use to Release Growth Hormone

A new G-protein-linked receptor for GH secretagogues (including MK-677, GHRP-6, and hexarelin) was identified and characterized, distinct from the GHRH receptor.

Pong, S S et al.·Molecular endocrinology (Baltimore·1996·Strong Evidencein-vitro
RPEP-00380In VitroStrong Evidence1996RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

A specific high-affinity G-protein-linked receptor for GH secretagogues was identified, operating through a distinct signaling pathway from GHRH.

Key Numbers

How They Did This

Molecular biology approach using receptor binding assays, G-protein coupling analysis, and signaling pathway characterization to identify and characterize the GHS receptor.

Why This Research Matters

Identifying this receptor was a landmark discovery that explained how GH secretagogues work and led directly to the discovery of ghrelin — the body's natural hunger hormone.

The Bigger Picture

This receptor identification was one of the most significant discoveries in endocrinology of the 1990s. It led to the discovery of ghrelin (1999), connecting growth hormone regulation to appetite, metabolism, and energy homeostasis.

What This Study Doesn't Tell Us

Initial characterization study. The receptor's natural ligand was not yet identified. Full tissue distribution and physiological role remained to be determined.

Questions This Raises

  • ?What is the endogenous ligand for this receptor?
  • ?What is the full tissue distribution and physiological role of this receptor?

Trust & Context

Key Stat:
New receptor identified A specific high-affinity receptor for all GH secretagogues was identified, distinct from the GHRH receptor
Evidence Grade:
Strong molecular biology evidence identifying a novel receptor. A landmark finding confirmed by subsequent research and the discovery of ghrelin.
Study Age:
Published in 1996, this is a landmark receptor discovery paper. The receptor (GHS-R1a) and its natural ligand ghrelin were fully characterized by 1999.
Original Title:
Identification of a new G-protein-linked receptor for growth hormone secretagogues.
Published In:
Molecular endocrinology (Baltimore, Md.), 10(1), 57-61 (1996)
Database ID:
RPEP-00380

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was discovered about this receptor?

Scientists identified a specific receptor protein that MK-677, GHRP-6, hexarelin, and other GH secretagogues all bind to. This receptor is now called GHS-R1a (growth hormone secretagogue receptor type 1a), and its natural ligand turned out to be ghrelin.

Why is this receptor discovery important for GH peptide users?

It explained exactly how GH secretagogues work — by binding a specific receptor distinct from GHRH's receptor. This is why combining GHRPs with GHRH produces synergistic effects: they activate two completely separate pathways for releasing growth hormone.

Read More on RethinkPeptides

Cite This Study

RPEP-00380·https://rethinkpeptides.com/research/RPEP-00380

APA

Pong, S S; Chaung, L Y; Dean, D C; Nargund, R P; Patchett, A A; Smith, R G. (1996). Identification of a new G-protein-linked receptor for growth hormone secretagogues.. Molecular endocrinology (Baltimore, Md.), 10(1), 57-61.

MLA

Pong, S S, et al. "Identification of a new G-protein-linked receptor for growth hormone secretagogues.." Molecular endocrinology (Baltimore, 1996.

RethinkPeptides

RethinkPeptides Research Database. "Identification of a new G-protein-linked receptor for growth..." RPEP-00380. Retrieved from https://rethinkpeptides.com/research/pong-1996-identification-of-a-new

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.